{
    "SPADE_UN_27472": {
        "Sequence Information": {
            "Peptide Name": "Antimicrobial peptide (LLKK)2",
            "Sequence": "LLKKLLKK",
            "Sequence Length": 8,
            "Biological Activity": [
                "Anti-Gram+",
                "Antifungal",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Synthetic cationic amphiphilic ?-helical peptides as antimicrobial agents.",
                    "Pubmed ID": "21168911",
                    "Reference": "Biomaterials. 2011;32:2204-2212",
                    "Author": "Wiradharma N, Khoe U, Hauser CA, Seow SV, Zhang S, Yang YY",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/21168911"
                },
                {
                    "Title": "Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin.",
                    "Pubmed ID": "24314557",
                    "Reference": "Biomaterials. 2014;35:2032-2038",
                    "Author": "Khara JS, Wang Y, Ke XY, Liu S, Newton SM, Langford PR, Yang YY, Ee PL",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/24314557"
                },
                {
                    "Title": "Short Synthetic ?-Helical-Forming Peptide Amphiphiles for Fungal Keratitis Treatment In Vivo.",
                    "Pubmed ID": "28081296",
                    "Reference": "Adv Healthc Mater. 2017;:",
                    "Author": "Wu H, Liu S, Wiradharma N, Ong ZY, Li Y, Yang YY, Ying JY",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/28081296"
                },
                {
                    "Title": "Designing ?-helical peptides with enhanced synergism and selectivity against Mycobacterium smegmatis: Discerning the role of hydrophobicity and helicity.",
                    "Pubmed ID": "26380930",
                    "Reference": "Acta Biomater. 2015;28:99-108",
                    "Author": "Khara JS, Lim FK, Wang Y, Ke XY, Voo ZX, Yang YY, Lakshminarayanan R, Ee PL",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/26380930"
                }
            ],
            "Mass": 983.33,
            "PI": 10.48,
            "Net Charge": 4,
            "Hydrophobicity": -0.05,
            "Frequent Amino Acids": "KL",
            "Absent Amino Acids": "ACDEFGHIMNOPQRSTUVWY",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 4,
            "Polar Residues": 4,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_27472",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_06017",
                    "Similarity": 1.0,
                    "Sequence": "LLWKLLKKLLK"
                },
                {
                    "SPADE_ID": "SPADE_N_06282",
                    "Similarity": 1.0,
                    "Sequence": "LKLLKKLLKKLLKLL"
                },
                {
                    "SPADE_ID": "SPADE_N_06540",
                    "Similarity": 1.0,
                    "Sequence": "CLLKKLLKKLLKK"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=>500 µg/ml,Rat erythrocytes:50% Hemolysis=>1000 µg/ml",
            "Target Organism": "Bacillus subtilis ATCC 23857(MIC=500µg/ml),Candida albicans ATCC 10231(MIC=250-500µg/ml),Mycobacterium smegmatis ATCC 14468(MIC=125µg/ml),Mycobacterium bovis BCG(MIC=500µg/ml),Mycobacterium tuberculosis H37Rv(MIC=>500µg/ml),Mycobacterium tuberculosis CSU87(MIC=>500µg/ml)"
        }
    }
}